Redhill Biopharma
RDHL
£1.11
Share price
-9.20%
Change (1 day)
-85.53%
Change (1 year)
Categories
EPS for Redhill Biopharma (RDHL)
EPS in 2023 (TTM): -£602.98
According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -£524.17. In 2017 the company made an earnings per share (EPS) of -£1,872 a decrease over its 2016 EPS that were of -£1,647.
EPS history for Redhill Biopharma from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -£602.98 | |
| 2017 | -£1,872 | 13.64% |
| 2016 | -£1,647 | 9.12% |
| 2015 | -£1,510 | 68.01% |
| 2014 | -£898.57 | -25.93% |
| 2013 | -£1,213 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | £2.13 | -100.41% | 🇫🇷 France |
 Merck MRK | £5.16 | -100.99% | 🇺🇸 USA |
 GlaxoSmithKline GSK | £1.17 | -100.22% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | £0.91 | -100.17% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | -£0.85 | -99.84% | 🇮🇱 Israel |